Q3B2E1 AF NFT

Leucine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihjji35darqaz2wgqac3f7o275p3ez2464unmerez3uwnbzgxivvq/metadata.json
IPFS of structure file: 
bafybeicdgaqinhuny2d6m6o2lva7vgkhxa7o6arwumgpnsq3i5v7toimo4/AF-Q3B2E1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x6Ed09D80e98fE15DE51C9E7a8896AbF1f2365C3e
First NFT owner address (bech32): 
genesis1dmgfmq8f3ls4meguneag394t78ervhp7h90qf8
Current NFT ID #449948 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
449948
Accession (UniProt):
Q3B2E1
Name::
Leucine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Chlorobium luteolum (strain DSM 273 / BCRC 81028 / 2530)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q3B2E1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q3B2E1|SYL_CHLL3 Leucine--tRNA ligase OS=Chlorobium luteolum (strain DSM 273 / BCRC 81028 / 2530) OX=319225 GN=leuS PE=3 SV=1 MKYDFSHTEKKWQAYWQEHGTFQAEEGQEKPKYYVLDMFPYPSGSGLHVGHLEGYTASDIVARYRRSRGNNVLHPMGWDAFGLPAEQYAIKTGTHPSLTTENNIRSFRETLQAMGFSYDWSREINTTDPGYFRWTQWIFLKLYEMGLAYQSEVDVNWCVELRAVLANEEVEEKIAEGLTVVRRPLRQWVLKITAYAERLLLDLDGLDWPENVKQMQRNWIGRSEGVEVDFELRCHRKMLRVYTTRPDTLFGATYLVISPEHPMAEKLATAPQLVEVKNYISKAKLKTELERTGLQKDKTGVFTGSYAINPANGEALPVWISDFVLTSYGTGAIMSVPAHDSRDWEFAKKFGLPIVEVVKSPHDVQDAVYEGKDSTAVNSSNSEISLDGLAFPEAFERMASWLELKKCGERKVNYRLRDWIFSRQRYWGEPIPVKHYEDGSLGTETDLPLRLPEVEAYQPTETGESPLANIPEWLYGTDGKGAFRRETNTMPQWAGSCWYYLRFIDPRNSEHLVDAEKEHYWMNVDLYIGGAEHAVLHLLYARFWHKVLYDLKVVSTKEPFQKLFNQGMILGEDGEKMSKSRGNVIPADHVLEKYGADAVRLYEMFLGPLEQVKPWNTNGIEGVSRFLNRVWRLVHPDTEGPAAVLDEAAMPGELLRRMHKTVKKVREDTECLKFNTAIAEMMVFVNDLHRTGNRNREAIETLVLLLAPYAPHISEELWEALGHPESIARAPFPTFDPALAANDVLTIAVQVNGKLRGTFEAAKDASKEEMLEAARAVESVRKFIEGSTVVKEIVVPGKLINFAVK